R Patell, L Rybicki, KR McCrae… - American journal of …, 2017 - Wiley Online Library
Inpatient venous thromboembolism (VTE) is a priority preventable illness; risk in cancer varies and prophylaxis is inconsistently used. A previously validated tool (Khorana …
A Parker, E Peterson, AYY Lee, C de Wit… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• The Khorana score is validated for risk of venous thromboembolism (VTE) in cancer outpatients.• We conducted a multicenter analysis of medically hospitalized cancer …
DE Angelini, MT Greene, JN Wietzke, SA Flanders… - Blood, 2016 - Elsevier
Background Current guidelines recommend all cancer inpatients receive pharmacologic VTE prophylaxis in the absence of contraindications. This is extrapolated from trials showing …
6598 Background: Quality panels and regulators have focused on inpatient venous thromboembolism (VTE) as a priority preventable illness. VTE is very prevalent in cancer but …
The Khorana score is recommended for guiding primary venous thromboembolism (VTE) prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
AA Khorana, M Dalal, J Lin, GC Connolly - Cancer, 2013 - Wiley Online Library
BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
A Chaudhury, A Balakrishnan, C Thai, B Holmstrom… - 2016 - ashpublications.org
BACKGROUND: Venous thromboembolism is a well-known complication of malignancy. The Khorana Risk Score (KRS) utilizes the type of cancer, blood counts, and body mass …
FI Mulder, M Candeloro, PW Kamphuisen… - …, 2019 - ncbi.nlm.nih.gov
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …
DR Douce, CE Holmes, M Cushman… - Journal of Thrombosis …, 2019 - Elsevier
Abstract Background The Khorana Score is a validated risk score for predicting 6‐month incidence of cancer‐associated venous thromboembolism (CAT) among patients starting …